1 |
Kamat S, Kumari M, Jayabaskaran C. Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2. J Control Release 2021;338:813-36. [PMID: 34478750 DOI: 10.1016/j.jconrel.2021.08.046] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Tu B, Wang H, An X, Qu J, Li Q, Gao Y, Shi M, Qiu H, Huang Y. Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants. Acta Pharm Sin B 2022. [PMID: 35169535 DOI: 10.1016/j.apsb.2022.01.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Sanna V, Satta S, Hsiai T, Sechi M. Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
4 |
Valdivia-Olivares RY, Rodriguez-Fernandez M, Álvarez-Figueroa MJ, Kalergis AM, González-Aramundiz JV. The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination. Vaccines (Basel) 2021;9:1420. [PMID: 34960166 DOI: 10.3390/vaccines9121420] [Reference Citation Analysis]
|
5 |
Brannon ER, Guevara MV, Pacifici NJ, Lee JK, Lewis JS, Eniola-adefeso O. Polymeric particle-based therapies for acute inflammatory diseases. Nat Rev Mater. [DOI: 10.1038/s41578-022-00458-5] [Reference Citation Analysis]
|
6 |
Tan RSL, Hassandarvish P, Chee CF, Chan LW, Wong TW. Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine. Carbohydr Polym 2022;290:119500. [PMID: 35550778 DOI: 10.1016/j.carbpol.2022.119500] [Reference Citation Analysis]
|